Venkataraman, director of Sarcoma Pathways and physician at Dana-Farber Cancer Institute, in Boston, explained that treatment ...
Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies ...
Kindi Barrie has faced challenge after challenge in her 16 years. Recently, her right foot was amputated in hopes of stopping ...
Zai Lab Limited today announced financial results for the third quarter of 2025, along with recent product highlights and corporate updates. "Zai Lab is entering the next phase of our growth, powered ...